Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$334M |
| 2 |
GSK
GSK
|
+$231M |
| 3 |
LO
LORILLARD INC COM STK
LO
|
+$188M |
| 4 |
Verizon
VZ
|
+$173M |
| 5 |
Mastercard
MA
|
+$159M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$5.07B |
| 2 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$840M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$781M |
| 4 |
Bausch Health
BHC
|
+$520M |
| 5 |
Meta Platforms (Facebook)
META
|
+$426M |
Sector Composition
| 1 | Healthcare | 14.28% |
| 2 | Technology | 10.33% |
| 3 | Financials | 9.22% |
| 4 | Energy | 6.79% |
| 5 | Consumer Discretionary | 6.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Emergent Biosolutions
EBS
$434M
| $30K | ﹤0.01% |
1,081
-982
| -48% | -$27.3K |
|
2802
First Financial Bancorp
FFBC
$2.46B
| $30K | ﹤0.01% |
1,729
-1,558
| -47% | -$27K |
|
2803
Nelnet
NNI
$4.46B
| $30K | ﹤0.01% |
627
-615
| -50% | -$29.4K |
|
|
XIN
2804
DELISTED
Xinyuan Real Estate
XIN
| $30K | ﹤0.01% |
1,539
-13
| -0.8% | -$253 |
|
|
CNSL
2805
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $30K | ﹤0.01% |
1,517
-3,820
| -72% | -$75.5K |
|
|
RDUS
2806
DELISTED
Radius Health, Inc.
RDUS
| $30K | ﹤0.01% |
729
+288
| +65% | +$11.9K |
|
|
DPLO
2807
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $30K | ﹤0.01% |
850
-90
| -10% | -$3.18K |
|
|
ADEP
2808
DELISTED
ADEPT TECHNOLOGY, INC. NEW
ADEP
| $30K | ﹤0.01% |
+5,000
| New | +$30K |
|
2809
BioCryst Pharmaceuticals
BCRX
$1.66B
| $29K | ﹤0.01% |
3,182
-3,109
| -49% | -$28.3K |
|
2810
Fomento Económico Mexicano
FMX
$32B
| $29K | ﹤0.01% |
304
-3,669
| -92% | -$350K |
|
2811
Ituran Location and Control
ITRN
$696M
| $29K | ﹤0.01% |
1,341
+217
| +19% | +$4.69K |
|
2812
REX American Resources
REX
$1.01B
| $29K | ﹤0.01% |
1,446
-84
| -5% | -$1.69K |
|
2813
Sturm, Ruger & Co
RGR
$600M
| $29K | ﹤0.01% |
584
-31,618
| -98% | -$1.57M |
|
2814
Rigel Pharmaceuticals
RIGL
$681M
| $29K | ﹤0.01% |
981
-1,045
| -52% | -$30.9K |
|
2815
Sportsman's Warehouse
SPWH
$117M
| $29K | ﹤0.01% |
4,100
-5,055
| -55% | -$35.8K |
|
|
INFI
2816
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $29K | ﹤0.01% |
2,291
-6,950
| -75% | -$88K |
|
|
GHDX
2817
DELISTED
Genomic Health, Inc.
GHDX
| $29K | ﹤0.01% |
965
-1,285
| -57% | -$38.6K |
|
|
EXAR
2818
DELISTED
Exar Corporation
EXAR
| $29K | ﹤0.01% |
2,887
-6,963
| -71% | -$69.9K |
|
|
CBR
2819
DELISTED
CIBER Inc.
CBR
| $29K | ﹤0.01% |
7,234
+2,813
| +64% | +$11.3K |
|
|
MCF
2820
DELISTED
Contango Oil & Gas Co.
MCF
| $29K | ﹤0.01% |
1,310
-5,274
| -80% | -$117K |
|
|
CEO
2821
DELISTED
CNOOC Limited
CEO
| $29K | ﹤0.01% |
205
-17,380
| -99% | -$2.46M |
|
2822
Federal Signal
FSS
$7.64B
| $28K | ﹤0.01% |
1,886
-6,484
| -77% | -$96.3K |
|
2823
Helios Technologies
HLIO
$1.8B
| $28K | ﹤0.01% |
665
-602
| -48% | -$25.3K |
|
2824
IDT Corp
IDT
$1.67B
| $28K | ﹤0.01% |
2,267
-30
| -1% | -$371 |
|
2825
National CineMedia
NCMI
$455M
| $28K | ﹤0.01% |
182
-165
| -48% | -$25.4K |
|